Wegovy and Zepbound are leading this year's weight loss drug prescription surgeByFrancisco VelasquezPublishedDecember 5, 2024
This startup says it can screen for over 50 cancers with one simple blood drawByBruce GilPublishedDecember 4, 2024
Eli Lilly says Zepbound beat rival weight loss drug Wegovy in head-to-head studyByWilliam GavinUpdatedDecember 4, 2024
Ozempic and other weight loss drugs could be making people drink less, study saysByBruce GilUpdatedDecember 2, 2024
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressedByBruce GilUpdatedNovember 26, 2024
The first fully robotic double-lung transplant just happened - here's all the detailsByBruce GilPublishedNovember 21, 2024
Weight loss drug makers want more insurance plans to cover Wegovy and ZepboundByBruce GilPublishedNovember 20, 2024
A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drugByBruce GilPublishedNovember 18, 2024
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundupByBruce GilPublishedNovember 8, 2024
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medicationsByBruce GilPublishedNovember 7, 2024
Now playing Sales of Novo Nordisk’s blockbuster weight loss drug Wegovy continue to soarPublishedNovember 6, 2024
Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drugByBruce GilPublishedNovember 4, 2024
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round upByBruce GilPublishedNovember 1, 2024
Knockoff weight loss drugs are having a moment. Eli Lilly isn't worriedByBruce GilPublishedOctober 30, 2024
